Source:http://linkedlifedata.com/resource/pubmed/id/17535017
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2007-7-2
|
pubmed:abstractText |
A method based on the direct injection of diluted urine for the identification and quantification of morphine, morphine-3-glucuronide, morphine-6-glucuronide, codeine, codeine-6-glucuronide, ethylmorphine, ethylmorphine-6-glucuronide and 6-acetylmorphine (6AM) in human urine by electrospray ionisation liquid chromatography-tandem mass spectrometry was validated for use as a confirmation procedure in urine drug testing. Four deuterium labelled analogues were used as internal standards: morphine-3-glucuronide-D3, morphine-D3, codeine-D3 and 6AM-D3. Twenty microlitre aliquots of urine were mixed with 80 mul of the internal standard solution in autosampler vials and 10 mul was injected. The chromatographic system consisted of a 2.0 x 100 mm C18 column and the gradient elution buffers used acetonitrile and 25 mmol/l formic acid. Two product ions produced from the protonated molecular ions were monitored in the selected reaction monitoring mode. The intra- and inter-assay variability (coefficient of variation) was below 10% at higher levels for all analytes, but at the reporting limits the variation was above 20% for 6AM, morphine-3-glucuronide and codeine-6-glucuronide. Ion suppression occurred early after injection but did not affect the identification and quantification of the analytes in authentic samples. The method was further validated by comparison with a reference gas chromatographic-mass spectrometric method using authentic urine samples. The two methods agreed almost completely (99%) regarding the identified analytes, but for the quantitative results there were slightly lower levels when measuring glucuronides directly as compared to total determination after hydrolysis by gas chromatography-mass spectrometry. We conclude that the presented liquid chromatographic-tandem mass spectrometric method is robust and reliable, and suitable for use as a confirmation method in urine drug testing for opiates
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1076-5174
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright (c) 2007 John Wiley & Sons, Ltd.
|
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
881-9
|
pubmed:dateRevised |
2009-11-3
|
pubmed:meshHeading |
pubmed-meshheading:17535017-Analgesics, Opioid,
pubmed-meshheading:17535017-Calibration,
pubmed-meshheading:17535017-Chromatography, Liquid,
pubmed-meshheading:17535017-Gas Chromatography-Mass Spectrometry,
pubmed-meshheading:17535017-Humans,
pubmed-meshheading:17535017-Immunochemistry,
pubmed-meshheading:17535017-Reproducibility of Results,
pubmed-meshheading:17535017-Spectrometry, Mass, Electrospray Ionization,
pubmed-meshheading:17535017-Substance Abuse Detection
|
pubmed:year |
2007
|
pubmed:articleTitle |
Validation of direct injection electrospray LC-MS/MS for confirmation of opiates in urine drug testing.
|
pubmed:affiliation |
Department of Medicine, Division of Clinical Pharmacology, Karolinska University Hospital, SE-17176 Stockholm, Sweden.
|
pubmed:publicationType |
Journal Article
|